Want answers fast?
Text us at (407)233-4006
Aspire Knowledge Blog

GLP-1 Longevity Benefits: Beyond Weight Loss

Discover how GLP-1 drugs offer more than weight loss when paired with hormone therapy.
Healthy middle-aged individual preparing nutritious meal and checking fitness tracker, representing comprehensive metabolic health through GLP-1 therapy combined with hormone optimization at Aspire Rejuvenation Clinic; Aspire Rejuvenation logo clearly visible

GLP-1 drugs like Ozempic, Mounjaro, and Wegovy are famous for weight loss, but they do much more — from protecting your heart to potentially supporting brain health. This article explains what GLP-1s really do beyond losing pounds, how combining them with hormone therapy prevents muscle loss and “Ozempic face,” and why Aspire Rejuvenation’s complete approach gets better lasting results. You’ll learn how GLP-1 therapy fits into real longevity medicine and what it can and can’t do for your health.

Key Takeaways

  • GLP-1 medications offer proven cardiovascular benefits, reducing heart attack and stroke risk by up to 20% — independent of weight loss alone
  • Emerging research shows GLP-1s may provide neuroprotective effects, potentially reducing Alzheimer’s and Parkinson’s disease risk
  • When used without proper hormone optimization, GLP-1 therapy can lead to significant muscle loss, metabolic slowdown, and the dreaded “Ozempic face”
  • Aspire Rejuvenation combines GLP-1 medications with testosterone therapy, peptides, and comprehensive metabolic monitoring — preserving lean muscle while maximizing fat loss
  • True metabolic health requires more than medication alone — lifestyle optimization, hormone balance, and ongoing medical oversight are essential for lasting results

Introduction

If you’ve spent any time scrolling through social media lately, you’ve seen them. The before-and-after photos. The celebrity transformations. The headlines screaming about “miracle weight loss drugs.” GLP-1 medications like Ozempic, Wegovy, and Mounjaro have completely dominated the wellness conversation for the past two years.

And for good reason — these drugs work. Really well. But here’s what the headlines aren’t telling you: weight loss is just the beginning.

So, are GLP-1 medications actually longevity drugs disguised as weight loss medications?

The short answer: they’re becoming that. The science is evolving fast, and what we’re discovering goes way beyond fitting into smaller jeans. We’re talking cardiovascular protection, potential neuroprotective effects, systemic inflammation reduction, and metabolic optimization that could extend healthspan significantly.

But here’s the catch, and it’s a big one. When GLP-1 medications are used in isolation, without proper hormone support and metabolic monitoring, patients often lose muscle mass along with fat, experience metabolic slowdown, and end up with that gaunt, aged appearance the internet has dubbed “Ozempic face.”

At Aspire Rejuvenation Clinic, our approach is rooted in comprehensive metabolic optimization. We’ve seen firsthand how combining GLP-1 therapy with testosterone optimization, growth hormone-releasing peptides, and targeted nutrition protocols delivers transformative results — rapid fat loss while preserving lean muscle, improved cardiovascular markers, enhanced energy, and that vital, healthy appearance that signals true wellness.

In this article, we’re going to show you what GLP-1 medications can actually do beyond weight loss, what they can’t do on their own, and how Aspire’s “Hormones First” approach ensures you get the longevity benefits without the downsides.

What Are GLP-1 Medications, Really?

Before we talk about longevity benefits, let’s start with the basics: what are GLP-1 medications, and how do they actually work?

GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in your gut that regulates blood sugar, appetite, and digestion. When you eat, your body releases GLP-1 to signal fullness, slow stomach emptying, and tell your pancreas to release insulin.

GLP-1 medications — including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and retatrutide — are synthetic versions of this hormone that last much longer in your system. They were originally developed to treat type 2 diabetes, but researchers quickly discovered they had a powerful side effect: significant weight loss.

Here’s how they work:

Appetite suppression — GLP-1s act on brain receptors that control hunger, dramatically reducing food cravings and making it easier to maintain a caloric deficit

Slowed gastric emptying — Food stays in your stomach longer, keeping you fuller for extended periods

Improved insulin sensitivity — Your body becomes more efficient at using glucose, reducing blood sugar spikes and improving metabolic function

Reduced inflammation — GLP-1 receptor activation has systemic anti-inflammatory effects throughout the body

The weight loss results are remarkable. Clinical trials show average weight loss of 15-20% of body weight over 68 weeks with semaglutide, and even more impressive results — up to 22.5% — with tirzepatide. But here’s what most people don’t realize: those results were achieved in conjunction with healthy lifestyle changes — diet modifications, exercise protocols, and behavioral interventions. The medication made it easier to adhere to those changes, but the changes themselves were non-negotiable.

And here’s the game-changer: the metabolic improvements happen independently of weight loss. That means even patients who don’t lose significant weight still see cardiovascular and metabolic benefits.

At Aspire Rejuvenation, we offer a comprehensive range of GLP-1 medications including semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and retatrutide — plus a full arsenal of complementary weight loss treatments including Bella Capsule, Tesofensine, AOD-9604, 5-Amino-1MQ, and lipotropic injections. These aren’t standalone prescriptions handed out through telemedicine apps. They’re integrated into personalized protocols that include hormone optimization, peptide support, body composition monitoring, and mandatory lifestyle coaching.

|| Learn more about our Medical Weight Loss Programs and how GLP-1 therapy fits into comprehensive metabolic health.

The Cardiovascular Benefits That Changed Everything

This is where GLP-1 medications stop being just weight loss drugs and start looking like legitimate longevity interventions.

The SELECT trial, published in 2023, was a game-changer. It showed that semaglutide reduced the risk of major cardiovascular events — heart attacks, strokes, and cardiovascular death — by 20% in patients with obesity and existing heart disease. And here’s the kicker: these benefits appeared before significant weight loss occurred.

That means the cardiovascular protection isn’t just about losing pounds. GLP-1 medications are doing something directly beneficial to the heart and blood vessels.

How? The mechanisms include:

Reduced systemic inflammation — GLP-1 receptor activation lowers inflammatory markers like C-reactive protein (CRP), which are strong predictors of cardiovascular disease

Improved endothelial function — The lining of your blood vessels works better, improving blood flow and reducing atherosclerosis risk

Blood pressure reduction — Many patients see modest but meaningful drops in blood pressure

Better lipid profiles — Improvements in triglycerides and cholesterol markers independent of weight loss

Reduced oxidative stress — Less cellular damage from free radicals

For patients in their 40s, 50s, 60s, and beyond who are focused on healthspan — not just losing weight — these cardiovascular benefits are potentially life-extending.

At Aspire, we monitor cardiovascular markers closely throughout GLP-1 therapy, tracking blood pressure, lipid panels, inflammatory markers, and metabolic function to ensure you’re getting the full systemic benefits.

The Emerging Science on Neuroprotection and Brain Health

If cardiovascular protection wasn’t enough, emerging research suggests GLP-1 medications may have neuroprotective effects, potentially reducing the risk of Alzheimer’s disease, Parkinson’s disease, and cognitive decline.

Here’s what the science is showing:

Reduced neuroinflammation — GLP-1 receptors exist throughout the brain, and activation appears to reduce inflammatory processes linked to neurodegenerative disease

Improved insulin signaling in the brain — “Type 3 diabetes” is now a proposed mechanism for Alzheimer’s disease, suggesting that insulin resistance in the brain contributes to cognitive decline. GLP-1s improve brain insulin sensitivity.

Neuroprotective effects in animal models — Studies in mice show that GLP-1 receptor activation protects neurons from damage and may promote neurogenesis (the growth of new brain cells)

Lower Alzheimer’s risk in observational studies — Some population studies show that diabetic patients taking GLP-1 medications have lower rates of dementia diagnosis compared to those on other diabetes drugs

This research is still early, and we need large-scale clinical trials before we can definitively call GLP-1s “brain health drugs.” But the signals are promising — and they align perfectly with the longevity medicine movement’s focus on preserving cognitive function into older age.

At Aspire Rejuvenation, brain health is part of our longevity protocols. We combine GLP-1 therapy with cognitive-supporting peptides like Dihexa, Semax, and NAD+ to maximize neuroprotective benefits and support long-term mental clarity.

|| Explore our Peptide Therapy programs for cognitive support and neuroprotection.

Systemic Inflammation Reduction and Metabolic Health

One of the most underrated benefits of GLP-1 medications is their impact on chronic inflammation, the root cause of virtually every age-related disease.

Chronic low-grade inflammation, sometimes called “inflammaging,” drives cardiovascular disease, diabetes, cancer, Alzheimer’s disease, arthritis, and metabolic dysfunction. It accelerates biological aging at the cellular level.

GLP-1 medications have been shown to reduce multiple inflammatory markers, including:

  • C-reactive protein (CRP)
  • Interleukin-6 (IL-6)
  • Tumor necrosis factor-alpha (TNF-α)
  • Oxidative stress markers

This anti-inflammatory effect happens systemically — throughout your entire body — and contributes to improved metabolic health, better insulin sensitivity, reduced joint pain, and potentially slower biological aging.

For patients focused on healthspan extension, this is huge. Reducing chronic inflammation is one of the most powerful longevity interventions we have.

At Aspire, we track inflammatory markers through comprehensive lab testing before, during, and after GLP-1 therapy to measure real improvements in metabolic and systemic health.

The “Ozempic Face” Problem — And How to Avoid It

Now for the uncomfortable truth that’s all over the internet: “Ozempic face.”

This term describes the gaunt, aged appearance some people develop on GLP-1 medications — sunken cheeks, hollow eyes, sagging skin, and an overall loss of facial volume that makes them look older, not healthier.

Why does this happen?

When you lose weight rapidly without proper nutritional support and hormone optimization, you lose both fat and muscle. Facial fat provides structure and youthful volume. When it disappears too quickly, especially in older adults whose skin has already lost elasticity, the result is that deflated, aged appearance.

But here’s the bigger problem: it’s not just your face. You’re losing muscle throughout your entire body, in your arms, legs, core, and organs. This is called sarcopenic – it’s basically obesity reversal done wrong.

Muscle loss during weight loss leads to:

Metabolic slowdown — Less muscle means lower basal metabolic rate, making it easier to regain weight

Reduced strength and function — You might be lighter, but weaker and less capable physically

Hormonal disruption — Rapid weight loss without hormone support can crash testosterone, thyroid, and growth hormone levels

Accelerated aging — Muscle is metabolically active tissue that supports longevity; losing it accelerates biological aging

This is where most GLP-1 prescriptions fail patients. The medication works for weight loss, but without comprehensive metabolic support, patients end up lighter but not healthier.

How Aspire Prevents Muscle Loss and “Ozempic Face”

At Aspire Rejuvenation, we don’t just hand you a GLP-1 prescription and wish you good luck. Unlike telemedicine services that simply mail you medication, Aspire requires patients to commit to healthy lifestyle changes as part of the protocol. Our programs are designed to preserve lean muscle mass while maximizing fat loss — delivering that tight, toned, vital appearance that signals true health.

Here’s how we do it:

Mandatory Lifestyle Integration — We require — not suggest, but require — diet modifications emphasizing high protein intake (1g per pound of goal body weight) and resistance training protocols. This isn’t optional. It’s the foundation that makes GLP-1 therapy work safely and effectively.

Testosterone Optimization — Maintaining optimal testosterone levels (for both men and women) is critical for preserving muscle during caloric restriction. We monitor and optimize testosterone throughout your weight loss journey.

Growth Hormone-Releasing Peptides — Peptides like CJC-1295/Ipamorelin and Tesamorelin stimulate natural growth hormone production, supporting muscle preservation, recovery, and fat metabolism.

Comprehensive Metabolic Monitoring — We track body composition, not just scale weight, using DEXA scans or bioimpedance analysis to ensure you’re losing fat, not muscle. We adjust protocols based on what the data shows, not just what the scale says.

Peptide Support for Tissue Repair — Peptides like BPC-157 and TB500 support connective tissue health, helping skin maintain elasticity during weight loss.

No Membership Fees, Just Results — Unlike subscription-based clinics, Aspire charges only for the treatments you actually need. No recurring costs, no binding commitments — just transparent pricing and personalized care.

The result? Patients lose significant body fat while maintaining and often building lean muscle. They look tighter, younger, and more vital, not gaunt and aged.

|| Discover how Hormone Replacement Therapy preserves muscle and metabolic health during weight loss.

What GLP-1 Medications Can’t Do

Now for the reality check: GLP-1 medications are powerful tools, but they’re not miracle cures, and anyone telling you otherwise is either misinformed or trying to sell you something.

GLP-1s Won’t Replace Healthy Habits

These medications make it easier to eat less and lose weight, but they don’t teach you how to eat well, manage stress, sleep properly, or stay active. When you stop taking them — and most people eventually do due to cost or side effects — you need sustainable habits in place, or the weight comes right back.

This is why Aspire makes lifestyle changes mandatory, not optional. We’re building a foundation that lasts beyond the medication.

GLP-1s Don’t Optimize Hormones

Weight loss alone doesn’t fix hormonal imbalances. In fact, rapid weight loss can worsen hormone dysfunction, crashing testosterone, thyroid, and growth hormone levels. You need active hormone optimization to maintain metabolic health during and after GLP-1 therapy.

GLP-1s Aren’t Longevity Drugs by Themselves

Yes, they have cardiovascular and metabolic benefits. But true longevity requires comprehensive hormone balance, cellular repair, inflammation control, mitochondrial health, and lifestyle factors. GLP-1s are one tool in a much larger toolkit.

GLP-1s Can Have Side Effects

Common side effects include nausea, vomiting, diarrhea, constipation, and fatigue, especially when starting or increasing doses. Rare but serious risks include pancreatitis, gallbladder disease, and potential thyroid concerns. This is why medical supervision is essential.

At Aspire Rejuvenation, GLP-1 therapy is never standalone. It’s integrated into personalized protocols that address the whole person — hormones, metabolism, lifestyle, and long-term health goals.

How Aspire Rejuvenation Approaches GLP-1 Therapy

At Aspire, GLP-1 medications are part of our broader “Hormones First” philosophy, a comprehensive approach to metabolic optimization that treats root causes, not just symptoms.

Step 1: Comprehensive Lab Testing

We start with detailed diagnostics assessing over 60 biomarkers, including hormone levels (testosterone, estrogen, thyroid, cortisol), metabolic markers (insulin, glucose, HbA1c), inflammatory markers (CRP, homocysteine), and lipid panels. This gives us a complete picture of your metabolic health and identifies any hormonal imbalances that need correction before or during GLP-1 therapy.

Step 2: Personalized Treatment Plans

Our board-certified providers design customized protocols based on your labs, health history, body composition, and goals. Your plan may include:

  • GLP-1 medication (semaglutide, tirzepatide, or retatrutide) with carefully titrated dosing
  • Testosterone optimization to preserve muscle mass
  • Growth hormone-releasing peptides for recovery and body composition
  • Thyroid support if needed
  • Mandatory nutritional guidance emphasizing high protein and nutrient density
  • Required exercise programming focused on resistance training
  • Access to complementary treatments like AOD-9604, Tesofensine, or lipotropic injections

Step 3: Ongoing Monitoring and Adjustments

GLP-1 therapy isn’t “set it and forget it.” We monitor your progress through regular check-ins, follow-up labs, and body composition analysis. We adjust medications, hormones, and protocols as needed to maximize fat loss while preserving muscle and metabolic health.

Step 4: Integration with Other Therapies

GLP-1s work best when combined with other longevity interventions. We often integrate:

  • Peptide therapy for tissue repair, cognitive support, and recovery
  • IV nutrient therapy to support cellular energy and detoxification
  • Regenerative treatments like exosomes for systemic inflammation reduction
  • Lifestyle optimization including sleep, stress management, and movement

Step 5: Transition and Maintenance Protocols

When you’re ready to discontinue GLP-1 therapy, we don’t just cut you loose. We create structured transition protocols to help you maintain your results through optimized hormones, sustainable habits, and ongoing metabolic support.

The result is superior outcomes compared to GLP-1 monotherapy — more fat loss, preserved muscle, better metabolic markers, and that vital, healthy appearance that signals true wellness.

Ready to optimize your metabolism the right way? Schedule a consultation with Aspire Rejuvenation and discover how GLP-1 therapy fits into your personalized longevity protocol.

Safety & Contraindications

GLP-1 medications are generally safe when prescribed and monitored by qualified medical professionals, but they’re not appropriate for everyone.

Who Should Avoid GLP-1 Therapy:

  • Individuals with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
  • Pregnant or breastfeeding women
  • People with severe gastrointestinal disease or gastroparesis
  • Those with active pancreatitis or history of severe pancreatitis
  • Patients with severe kidney disease

Common Side Effects:

  • Nausea, vomiting, diarrhea (usually temporary and improve with dose adjustment)
  • Constipation
  • Fatigue during initial weeks
  • Reduced appetite (this is expected, but severe aversion to food requires dose adjustment)
  • Potential hair thinning (usually temporary and improves with hormone optimization)

At Aspire Rejuvenation, safety is our top priority. Every patient undergoes thorough medical screening and comprehensive lab testing before starting GLP-1 therapy. We monitor progress closely and adjust protocols to ensure effectiveness while minimizing side effects.

FAQ

Q1: How long do I need to stay on GLP-1 medications?

A: Most patients use GLP-1 medications for 6-18 months during active weight loss, though some continue longer for metabolic maintenance. The key is using this window to establish sustainable habits and optimize hormones so you can maintain results after discontinuation. At Aspire, we create transition protocols to help you maintain your progress long-term.

Q2: How are GLP-1 medications administered at Aspire Rejuvenation?

A: GLP-1 medications are administered via subcutaneous injection, typically once weekly. We provide detailed injection training and ongoing support. The injections use very small needles and most patients find them quick and relatively painless. Your provider will guide you through proper technique and answer any questions.

Q3: Will I regain the weight after stopping GLP-1 medications?

A: This depends entirely on whether you’ve addressed the underlying metabolic and hormonal factors that contributed to weight gain in the first place. At Aspire, we focus on comprehensive optimization — fixing hormones, building sustainable habits, and preserving muscle mass — so you can maintain results after discontinuing medication.

Q4: Can I build muscle while on GLP-1 medications? A: Yes, but it requires proper hormone support and intentional effort. With optimized testosterone, adequate protein intake (1g per pound of goal body weight), and consistent resistance training, many patients actually improve body composition — losing fat while maintaining or even building lean muscle. This is why our integrated approach is so effective.

Q5: How much do GLP-1 medications cost at Aspire?

A: Costs vary depending on the specific medication and dosing protocol. At Aspire Rejuvenation, we believe in transparent pricing with no membership fees — you only pay for the treatments you need. Schedule a consultation to discuss your specific situation and get accurate pricing information.

Q6: Do the cardiovascular benefits continue after stopping GLP-1 therapy? A: Early research suggests that some metabolic improvements persist after discontinuation, especially if patients maintain weight loss and continue optimizing hormones and lifestyle factors. However, the full long-term effects are still being studied. This is another reason why comprehensive metabolic optimization — not just GLP-1 monotherapy — is so important.

Q7: What other weight loss medications does Aspire offer besides GLP-1s?

A: Beyond semaglutide, tirzepatide, and retatrutide, Aspire offers a comprehensive range of weight loss treatments including Bella Capsule, ECA Stack, L-Carnitine, Tesofensine, Phentermine, AOD-9604, 5-Amino-1MQ, and lipotropic injections. Your provider will recommend the best combination based on your goals, health status, and response to treatment.

Author & Review Attribution

Written by Joseph Lawrence (Chief Messaging Officer) Reviewed by Dr. Joe Clark / Tomo Marjanovic / Jade Rohn, Aspire Rejuvenation Clinic This article was written by a human being and is based on original research and synthesis.

At Aspire Rejuvenation, we follow rigorous sourcing and review standards to ensure every article reflects the most accurate and current medical information. Content is based on peer-reviewed studies, reputable medical journals, and guidance from leading health organizations. Every piece is reviewed by licensed medical professionals and updated regularly to maintain accuracy, integrity, and clinical relevance.

American Diabetes Association. (2024). Standards of care in diabetes—2024. Diabetes Care, 47(Supplement_1), S1-S321. https://doi.org/10.2337/dc24-SINT

Bergmann, N. C., Davies, M. J., Lingvay, I., & Knop, F. K. (2023). Semaglutide for the treatment of overweight and obesity: A review. Diabetes, Obesity and Metabolism, 25(1), 18-35. https://doi.org/10.1111/dom.14863

Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., Gardner, T. W., Garg, R., Garvey, W. T., Hirsch, I. B., Hurley, D. L., Izuora, K., Kosiborod, M., Olson, D., Patel, S. B., … Draznin, B. (2024). American Association of Clinical Endocrinology clinical practice guideline: Developing a diabetes mellitus comprehensive care plan—2022 update. Endocrine Practice, 28(10), 923-1049. https://doi.org/10.1016/j.eprac.2022.08.002

Capehorn, M. S., Catarig, A. M., Furberg, J. K., Janez, A., Price, H. C., Tadayon, S., Vergès, B., & Marre, M. (2020). Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10). Diabetes & Metabolism, 46(2), 100-109. https://doi.org/10.1016/j.diabet.2019.101117

Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038

Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G. K., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., Shah, S. J., Treppendahl, M. B., Verma, S., Petrie, M. C., & SELECT Trial Committees and Investigators. (2024). Semaglutide in patients with obesity-related heart failure and type 2 diabetes. New England Journal of Medicine, 390(15), 1394-1407. https://doi.org/10.1056/NEJMoa2313917

Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., Ryan, D. H., & SELECT Trial Investigators. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. https://doi.org/10.1056/NEJMoa2307563

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., Bergenstal, R. M., Buse, J. B., & LEADER Steering Committee on behalf of the LEADER Trial Investigators. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine, 375(4), 311-322. https://doi.org/10.1056/NEJMoa1603827

Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102

Newsome, P. N., Buchholtz, K., Cusi, K., Linder, M., Okanoue, T., Ratziu, V., Sanyal, A. J., Sejling, A. S., Harrison, S. A., & NN9931-4296 Investigators. (2021). A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. New England Journal of Medicine, 384(12), 1113-1124. https://doi.org/10.1056/NEJMoa2028395

Rubino, D. M., Greenway, F. L., Khalid, U., O’Neil, P. M., Rosenstock, J., Sørrig, R., Wadden, T. A., Wizert, A., Garvey, W. T., & STEP 8 Investigators. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA, 327(2), 138-150. https://doi.org/10.1001/jama.2021.23619

Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183

Ready to experience GLP-1 therapy done right?

Schedule a consultation with Aspire Rejuvenation and discover how our comprehensive approach combines GLP-1 medications with hormone optimization and peptide therapy for superior, sustainable results.

Aspire Rejuvenation Clinic Orlando

Virtual Visits Available!

Feel Like The Younger Version Of Yourself

Aspire Rejuvenation Clinic creates personalized protocols tailored to each patient’s unique physiology- grounded in science and guided by decades of medical expertise. Our mission is to set the standard in modern regenerative medicine with proven therapies that redefine what’s possible for your body and mind.

ASPIRE CLINIC LOCATIONS

Speak With Our Experts